Our story
- About us
- Latest
- Centres
Our science
- Mission
  - Discover
  - Develop
  - Deliver
- Approaches
- Explore by
Our people
- Researchers
- Governance
- Latest
  
  Feb 19, 2026
  
  First Group Leaders announced for new dedicated Parkinson's Research Centre
  
  In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research...
  Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Our partners
- Partnerships
- Initiatives
- Latest
  
  Jan 01, 2024
  
  Why partner with the UK DRI?
  
  The UK DRI is central to a rich and connected dementia research ecosystem, and we...
  Learn more Why partner with the UK DRI?
Careers
- Join us
  - Vacancies
  - Centres
- Latest
  
  Jan 01, 2024
  
  Why join the UK DRI?
  
  By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists...
  Learn more Why join the UK DRI?
Public Information
- Information
- Dementias
- Movement conditions

Lancet Neurol

Published Jan 09, 2020

Neuromyelitis optica in patients with increased interferon alpha concentrations.

Authors

Jac Williams, Sarah McGlasson, Sarosh Irani, Darragh Duffy, Yanick Crow, David Hunt

Read More

Abstract

PMID:31839246 | DOI:S1474-4422(19)30445-4

UK DRI Authors

Prof David Hunt

Group Leader

Investigating how innate immune activation causes damage to the microvasculature of the brain

Prof David Hunt